All data are based on the daily closing price as of November 11, 2026
b

Basel Medical Group Ltd

BMGL
1.93 USD
-3.47
-64.26%
* previous day closing price

Overview

Last close
1.93 usd
Market cap
36.26M usd
52 week high
9.16 usd
52 week low
0.49 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.2185
Price/Book Value
18.5764
Enterprise Value
73.34M usd
EV/Revenue
6.2073
EV/EBITDA
32.8706

Key financials

Revenue TTM
21.51M usd
Gross Profit TTM
8.34M usd
EBITDA TTM
-439833 usd
Earnings per Share
-0.61 usd
Dividend
N/A usd
Total assets
17.79M usd
Net debt
9.09M usd

About

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, knee and hip replacements, sports medicine/surgery, foot/ankle surgery, and physiotherapy services, minimally invasive orthopedic procedures, as well as neurology and neurosurgical treatments. It also provides health screening, mental health, woman's health, and general practice services. In addition, the company's services include consultation, medical diagnosis, and medical and surgical treatments. Basel Medical Group Ltd was incorporated in 2023 and is headquartered in Singapore.
  • Symbol
    BMGL
  • Exchange
    NASDAQ
  • Isin
    VGG0864B1114
  • Country
    Singapore
  • Sector
    Healthcare
  • Industry
    Medical Care Facilities
  • CEO
  • Headquarter
    Singapore
  • Web site
    https://baselmedical.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top